Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Merck's oral PCSK9 inhibitor leader reduces cholesterol in ph. 3
Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning.
James Waldron
Jun 9, 2025 9:00am
Biopsies illuminate potential of Candel's prostate cancer drug
May 22, 2025 6:57pm
Lilly links lepodisiran to durably lower lipoprotein in phase 2
Mar 31, 2025 4:24am
BioNTech posts survival data behind bispecific's phase 3 push
Mar 28, 2025 8:00am
Equillium misses primary, key secondaries, plans approval filing
Mar 27, 2025 9:52am
Candel's cancer survival data light path ahead in subpopulation
Mar 27, 2025 9:48am
